Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 4Advanced Solid Tumors 4Solid Tumors 2Solid Tumor 2Mesothelioma, Malignant 2Mesothelioma 2Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Breast Neoplasms 1Solid Malignancy 1Relapsed Pediatric Solid Tumor 1Cholangiocarcinoma of the Gallbladder 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Advanced Malignant Solid Neoplasm 1Advanced Cancers 1Advanced Cancer 1

Interventions

temsirolimus 1olaparib 1figitumumab 1etirinotecan pegol 1Vemurafenib 1Temozolomide 1Surveys and Questionnaires 1Sunitinib 1Referral and Consultation 1Gemcitabine 1Everolimus 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Cancer × Everolimus × Other solid neoplasm × Clear all
NCT01596140 2020-06-04

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
27 enrolled
Other solid neoplasm

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡